{"id":"https://openalex.org/A5119830833","orcid":null,"observed_orcids":[],"display_name":"Pradhi Srivasatava","raw_author_names":["Pradhi Srivasatava","Srivasatava, Pradhi"],"full_name":"Pradhi Srivasatava","works_count":3,"cited_by_count":13,"summary_stats":{"2yr_mean_citedness":4.333333333333333,"h_index":2,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5119830833","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I191972202","ror":"https://ror.org/02n9z0v62","display_name":"Amity University","country_code":"IN","type":"education","lineage":["https://openalex.org/I191972202"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I191972202","ror":"https://ror.org/02n9z0v62","display_name":"Amity University","country_code":"IN","type":"education","lineage":["https://openalex.org/I191972202"]}],"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":3,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","count":2,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","count":1,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","value":2.21e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","value":1.54e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","value":7.3e-06,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","value":6.1e-06,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","score":0.9370999932289124},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.673799991607666},{"id":"2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","score":0.6304000020027161},{"id":"126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","score":0.5264000296592712},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.4706999957561493}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":11},{"year":2026,"works_count":2,"oa_works_count":1,"cited_by_count":2}],"display_name_alternatives":["Pradhi Srivasatava","Srivasatava, Pradhi"],"block_key":"p srivasatava","works_api_url":"https://api.openalex.org/works?filter=author.id:A5119830833","updated_date":"2026-10-13T12:33:52","created_date":"2025-10-10T00:00:00"}